Published in Cancer Weekly, June 23rd, 2009
"The addition of bevacizumab to chemotherapy improved the efficacy over chemotherapy alone in both first and second line settings, although the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-06-23)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.